SecBot SecBot
8-K ·Filed Mar 5, 2026

RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.
NEUTRAL
Impact 5/10
Horizonweeks Processed8mo ago SEC0001437749-26-006991
8-K context-dependent: Items 3.03, 8.01
Actionable Insight • Neutral

Monitor RVPH price action after March 9, 2026 to see if the reverse split achieves sustained >$1.00 bid price for 10 consecutive days required for Nasdaq compliance. Watch for potential liquidity deterioration and whether the company can maintain compliance through March 27, 2026 deadline.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.20
T+0 close · Mar 5, 2026 · via day close
Latest settled
−85.71%
T+60 · $0.6000
Vs SPY
−97.01%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 5 $4.20entry
  2. T+1 · 9mo ago −14.29%α −12.97% · $3.60
  3. T+5 · 8mo ago −36.90%α −34.67% · $2.65
  4. T+20 · 8mo ago −82.86%α −79.07% · $0.7200
  5. T+60 · 6mo ago −85.71%α −97.01% · $0.6000
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Reviva Pharmaceuticals Holdings is implementing a 1-for-20 reverse stock split effective March 9, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement after receiving a delisting notice. The reverse split aims to increase the stock price but may reduce liquidity and does not address underlying business fundamentals.

Key Facts

  • Company is executing a 1-for-20 reverse stock split effective March 9, 2026
  • Reverse split is intended to regain compliance with Nasdaq's $1.00 minimum bid price requirement
  • Company received Nasdaq delisting notice on May 13, 2025 for failing to maintain $1.00 minimum bid price
  • Nasdaq granted an exception period through March 27, 2026 to demonstrate compliance
  • No fractional shares will be issued; fractional entitlements will be rounded up to the nearest whole share
  • CUSIP number will change to 76152G 209 while trading symbol RVPH remains unchanged

Financial Impact

The reverse stock split will reduce the number of outstanding shares by 95% (1:20 ratio) but will not change the company's $29M market capitalization or equity structure. No financial costs or dilution impact are disclosed.

share countstock priceliquidity

Risk Factors

  • Failure to maintain $1.00+ bid price for 10 consecutive days by March 27, 2026 could result in Nasdaq delisting
  • Reduced share count may decrease liquidity and increase volatility
  • Reverse split does not improve underlying business fundamentals or revenue prospects
  • Market perception of reverse splits as negative signal could pressure share price

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001437749-26-006991
Document: 0001437749-26-006991-index-headers.html0001437749-26-006991
Document: 0001437749-26-006991-index.html0001437749-26-006991
Document: 0001437749-26-006991.txt0001437749-26-006991

Track record

12 reports on RVPH

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +22.98% at T+20 after the Jul 10, 2026 report. 2 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Neutral 3/10 No price data
  2. Nov 12, 20264d ago Press Release Neutral 4/10 Entry $0.3533 Now $0.3504 −0.81% settles Feb 11
  3. Nov 9, 20267d ago DEF 14A Neutral 4/10 Entry $0.3521 Now $0.3504 −0.47% settles Feb 8
  4. Aug 12, 202613w ago Press Release Neutral 4/10 Entry $0.3521 to $0.3521 Now $0.3504 −0.47% · 0.00% +5.48% vs SPY
  5. Jul 10, 202618w ago 25-NSE Bearish 7/10 Entry $0.6200 to $0.5000 Now $0.3504 +43.48% ▲ +19.35% +22.24% vs SPY
  6. May 13, 202626w ago Press Release Bearish 7/10 Entry $0.3900 to $0.4303 Now $0.3504 +10.14% ▼ −10.33% −6.74% vs SPY
  7. May 13, 202626w ago 8-K Bearish 8/10 Entry $0.3521 to $0.4775 Now $0.3504 +0.47% ▼ −35.62% −31.19% vs SPY
  8. Apr 15, 202630w ago 8-K Neutral 5/10 Entry $0.8900 to $0.5731 Now $0.3504 −60.62% ▼ −35.61% −43.74% vs SPY
  9. Mar 30, 202633w ago Press Release Mixed 6/10 Entry $0.6600 to $0.6000 Now $0.3504 −46.90% ▼ −9.09% −25.58% vs SPY
  10. Mar 18, 202634w ago Press Release Bearish 6/10 Entry $0.8300 to $0.7000 Now $0.3504 +57.78% ▲ +15.66% +30.01% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 7h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026